Does TORSEMIDE Cause Nephrocalcinosis? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Nephrocalcinosis have been filed in association with TORSEMIDE (Torsemide). This represents 0.2% of all adverse event reports for TORSEMIDE.
12
Reports of Nephrocalcinosis with TORSEMIDE
0.2%
of all TORSEMIDE reports
0
Deaths
12
Hospitalizations
How Dangerous Is Nephrocalcinosis From TORSEMIDE?
Of the 12 reports, 12 (100.0%) required hospitalization.
Is Nephrocalcinosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORSEMIDE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TORSEMIDE Cause?
General physical health deterioration (1,233)
Dyspnoea (1,176)
Acute kidney injury (975)
Dizziness (870)
Oedema peripheral (823)
Fall (707)
Dehydration (705)
Cardiac failure (698)
Hypotension (689)
Fatigue (635)
What Other Drugs Cause Nephrocalcinosis?
FUROSEMIDE (111)
CALCIUM (65)
CALCITRIOL (64)
LANSOPRAZOLE (51)
OMEPRAZOLE (49)
ASFOTASE ALFA (45)
PANTOPRAZOLE (41)
PREDNISOLONE (39)
SODIUM, DIBASIC\SODIUM, MONOBASIC (32)
DENOSUMAB (31)
Which TORSEMIDE Alternatives Have Lower Nephrocalcinosis Risk?
TORSEMIDE vs TOVIAZ
TORSEMIDE vs TOVORAFENIB
TORSEMIDE vs TOZINAMERAN
TORSEMIDE vs TRABECTEDIN
TORSEMIDE vs TRACLEER